Gene · 51135
Papers3,419
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,419
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Degradation by Design: New Cyclin K Degraders from Old CDK Inhibitors. | ACS Chem Biol | 2024 | 38193430 | PubTator, text mining | PubMed |
| The exploration of glucocorticoid pathway based on disease severity in COVID-19 patients. | Heliyon | 2024 | 38187222 | PubTator, text mining | PubMed |
Comparative evaluation of propolis mouthwash with 0.2% chlorhexidine mouthwash as an adjunct to mechanical therapy in improving the periodontitis among perimenopausal women: a randomized controlled trial. | BMC Oral Health | 2024 | 38183081 | PubTator, text mining | PubMed |
| Lipid metabolism-derived FAAH is a sensitive marker for the prognosis and immunotherapy of osteosarcoma patients. | Heliyon | 2024 | 38169921 | PubTator, text mining | PubMed |
| New molecular targets in the treatment of rheumatoid arthritis. | Curr Opin Rheumatol | 2024 | 38165286 | PubTator, text mining | PubMed |
| Induced protein degradation for therapeutics: past, present, and future. | J Clin Invest | 2024 | 38165043 | PubTator, text mining | PubMed |
| The novel mechanism of human norovirus induced diarrhea: Activation of PKD2 caused by HuNoVs destroyed AQP3 expression through AP2γ in intestinal epithelial cells. | Life Sci | 2024 | 38103725 | PubTator, text mining | PubMed |
| U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review). | Oncol Rep | 2024 | 37975232 | PubTator, text mining | PubMed |
| Diagnosis of IRAK-4-deficiency by flow cytometric measurement of IκB-α degradation. | Clin Chem Lab Med | 2024 | 37929815 | PubTator, text mining | PubMed |
| Proximity extension assay-based discovery of biomarkers for disease activity in chronic inflammatory demyelinating polyneuropathy. | J Neurol Neurosurg Psychiatry | 2024 | 37879899 | PubTator, text mining | PubMed |
| Understanding the immune profile of sudden infant death syndrome - proteomic perspectives. | Acta Paediatr | 2024 | 37792385 | PubTator, text mining | PubMed |
| Diffuse large B-cell lymphoma involving the central nervous system: biologic rationale for targeted therapy. | Haematologica | 2024 | 37706315 | PubTator, text mining | PubMed |
| Organ-specific off-target effects of Pim/ZIP kinase inhibitors suggest lack of contractile Pim kinase activity in prostate, bladder, and vascular smooth muscle. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 37658212 | PubTator, text mining | PubMed |
| Recent advances in targeted protein degraders as potential therapeutic agents. | Mol Divers | 2024 | 36790583 | PubTator, text mining | PubMed |
| The IRAK-M death domain: a tale of three surfaces. | Front Mol Biosci | 2023 | 38268724 | PubTator, text mining | PubMed |
| New insights of platelet endocytosis and its implication for platelet function. | Front Cardiovasc Med | 2023 | 38264257 | PubTator, text mining | PubMed |
| Oral Absorption of Middle-to-Large Molecules and Its Improvement, with a Focus on New Modality Drugs. | Pharmaceutics | 2023 | 38258058 | PubTator, text mining | PubMed |
| Quercetin inhibits the activity and function of dendritic cells through the TLR4/IRAK4/NF-κB signalling pathway. | Contemp Oncol (Pozn) | 2023 | 38239865 | PubTator, text mining | PubMed |
| Mitochondrial DNA Sensing Pathogen Recognition Receptors in Systemic Sclerosis Associated Interstitial Lung Disease: A Review. | Curr Treatm Opt Rheumatol | 2023 | 38230363 | PubTator, text mining | PubMed |
| Predicting drug-target binding affinity with cross-scale graph contrastive learning. | Brief Bioinform | 2023 | 38221904 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51135/papers?page=11